Posted by Lauren Steadman on Jan 19th, 2025
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 7,680,000 shares, a growth of 19.8% from the December 15th total...
More of this article »